Damages

Pharma in Brief’s 2023 Year in Review and Trends for 2024The Ontario Superior Court dismisses a generic manufacturer’s claim for damages under section 8 of the PM(NOC) RegulationsSupreme Court denies leave to appeal in generic Statute of Monopolies case

Intellectual property

Drug Pricing Update: PMPRB releases final price-review GuidelinesFederal Court upholds patent validity and issues injunction and delivery up order against biosimilarPharma in Brief’s 2024 Year in Review and Trends for 2025

Life sciences and healthcare

Drug shortages: New requirements proposed for the Food and Drug RegulationsPharma in Brief’s 2024 Year in Review and Trends for 2025Drug Pricing Update: PMPRB launches consultation on Draft Guidelines for price review

Pharmaceuticals and life sciences

Accelerating drug access in Canada: New pathways from the pCPA and Province of OntarioPharmacare update: Canada’s Drug Agency launches Appropriate Use StrategyNational Pharmacare: Canada’s Drug Agency Consulting on National Bulk Purchasing Strategy

Uncategorized

Drug Pricing Update: PMPRB releases final price-review GuidelinesCADTH advisory panel consults on framework for pan-Canadian formularyAmendments to the Federal Courts Rules